0001209191-17-036620.txt : 20170531
0001209191-17-036620.hdr.sgml : 20170531
20170531210150
ACCESSION NUMBER: 0001209191-17-036620
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170526
FILED AS OF DATE: 20170531
DATE AS OF CHANGE: 20170531
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SILVERNAIL LAUREN P
CENTRAL INDEX KEY: 0001225755
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 17883016
MAIL ADDRESS:
STREET 1: 15279 ALTON PARKWAY
STREET 2: SUITE #100
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-26
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001225755
SILVERNAIL LAUREN P
C/O REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD
NEWARK
CA
94560
0
1
0
0
CFO, CBO & Secretary
Common Stock
2017-05-26
4
M
0
23000
8.70
A
59566
D
Stock Option (Right to Buy)
8.70
2017-05-26
4
M
0
23000
0.00
D
2023-05-23
Common Stock
23000
73373
D
The Option became fully vested as of March 18, 2017.
/s/ Gordon Ho, Attorney-in-fact
2017-05-31